ID24333A - PROCESS FOR PROTECTION OF SOMEONE TO THE CONTAMINATION OF THE AS A RESULT OF TRANSDERMAL ORAL USE SYSTEMS WHICH DOESN'T TRUE - Google Patents

PROCESS FOR PROTECTION OF SOMEONE TO THE CONTAMINATION OF THE AS A RESULT OF TRANSDERMAL ORAL USE SYSTEMS WHICH DOESN'T TRUE

Info

Publication number
ID24333A
ID24333A IDW20000399A ID20000399A ID24333A ID 24333 A ID24333 A ID 24333A ID W20000399 A IDW20000399 A ID W20000399A ID 20000399 A ID20000399 A ID 20000399A ID 24333 A ID24333 A ID 24333A
Authority
ID
Indonesia
Prior art keywords
doesn
someone
contamination
true
protection
Prior art date
Application number
IDW20000399A
Other languages
Indonesian (id)
Inventor
Frank Becher
Ann-Katrin Klink
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ID24333A publication Critical patent/ID24333A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Radiation-Therapy Devices (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

According to the invention, denaturing agents are added to a transdermal therapeutic system to prevent misuse in the form of unauthorised oral application.
IDW20000399A 1997-10-01 1998-09-18 PROCESS FOR PROTECTION OF SOMEONE TO THE CONTAMINATION OF THE AS A RESULT OF TRANSDERMAL ORAL USE SYSTEMS WHICH DOESN'T TRUE ID24333A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19743484A DE19743484C1 (en) 1997-10-01 1997-10-01 Transdermal patches containing substance with unpleasant taste

Publications (1)

Publication Number Publication Date
ID24333A true ID24333A (en) 2000-07-13

Family

ID=7844345

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000399A ID24333A (en) 1997-10-01 1998-09-18 PROCESS FOR PROTECTION OF SOMEONE TO THE CONTAMINATION OF THE AS A RESULT OF TRANSDERMAL ORAL USE SYSTEMS WHICH DOESN'T TRUE

Country Status (23)

Country Link
EP (1) EP1019032B1 (en)
JP (2) JP4755338B2 (en)
KR (1) KR100552102B1 (en)
AT (1) ATE228356T1 (en)
AU (1) AU759609B2 (en)
CA (1) CA2305432C (en)
DE (2) DE19743484C1 (en)
DK (1) DK1019032T3 (en)
ES (1) ES2188021T3 (en)
HK (1) HK1029919A1 (en)
HU (1) HU226644B1 (en)
ID (1) ID24333A (en)
IL (1) IL134479A (en)
MY (1) MY116425A (en)
NO (2) NO319163B1 (en)
NZ (1) NZ503643A (en)
PL (1) PL193066B1 (en)
PT (1) PT1019032E (en)
SK (1) SK3332000A3 (en)
TR (1) TR200000461T2 (en)
TW (1) TW431894B (en)
WO (1) WO1999016428A1 (en)
ZA (1) ZA988904B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19743484C1 (en) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermal patches containing substance with unpleasant taste
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
DE102004019916A1 (en) * 2004-04-21 2005-11-17 Grünenthal GmbH Anti-abuse drug-containing patch
CN112823191A (en) * 2018-10-17 2021-05-18 日荣新化株式会社 Adhesive sheet and method for producing same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
DE4342174C1 (en) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermal therapeutic system and a method for producing a transdermal therapeutic system for the combined transdermal application of physostigmine and scopolamine for the prophylaxis and pretreatment of poisoning by highly toxic organophosphorus neurotoxins, in particular Soman and its use
DE19743484C1 (en) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermal patches containing substance with unpleasant taste

Also Published As

Publication number Publication date
EP1019032B1 (en) 2002-11-27
NO20001691L (en) 2000-03-31
AU759609B2 (en) 2003-04-17
JP2001517695A (en) 2001-10-09
ATE228356T1 (en) 2002-12-15
PL339736A1 (en) 2001-01-02
HUP0003476A3 (en) 2001-04-28
HU226644B1 (en) 2009-05-28
ES2188021T3 (en) 2003-06-16
NO20001492D0 (en) 2000-03-22
TW431894B (en) 2001-05-01
CA2305432C (en) 2007-04-03
KR20010030886A (en) 2001-04-16
SK3332000A3 (en) 2000-11-07
HK1029919A1 (en) 2001-04-20
TR200000461T2 (en) 2000-09-21
PL193066B1 (en) 2007-01-31
NO319163B1 (en) 2005-06-27
HUP0003476A2 (en) 2001-02-28
PT1019032E (en) 2003-04-30
DE59806468D1 (en) 2003-01-09
MY116425A (en) 2004-01-31
NO20001691D0 (en) 2000-03-31
CA2305432A1 (en) 1999-04-08
DE19743484C1 (en) 1999-01-28
NO20001492L (en) 2000-03-22
WO1999016428A1 (en) 1999-04-08
IL134479A (en) 2005-07-25
AU9626598A (en) 1999-04-23
IL134479A0 (en) 2001-04-30
DK1019032T3 (en) 2003-03-10
JP4755338B2 (en) 2011-08-24
ZA988904B (en) 1999-04-12
NZ503643A (en) 2003-05-30
JP2009035561A (en) 2009-02-19
KR100552102B1 (en) 2006-02-13
EP1019032A1 (en) 2000-07-19

Similar Documents

Publication Publication Date Title
BR0008176A (en) Anti-seizure derivatives useful in the treatment of cluster headaches
ID29552A (en) TRIAZOLA COMPOUNDS AND ITS USE
BR9710993A (en) Anticonvulsant derivatives useful in the treatment of amyotrophic lateral sclerosis (als)
PL337329A1 (en) Oxazolydinone based antibacterial agents comprising a thiocarbonyl functional group
NZ331189A (en) Method of detection of influenza virus using neuraminidase binders
ATE295347T1 (en) SUBSTANCES AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
FI953442A0 (en) Freeze-dried beads containing gonadotropin
NO965516L (en) Sterol derivatives used to regulate meiosis
PH31335A (en) Naphthalamides as central nervous system agent.
DE69801577D1 (en) DUST CONTROL COMPOSITION
BR9913072A (en) Azacyclic ring systems, pharmaceutical composition, and process to induce analgesia
ID29295A (en) PYRIMIDINONE COMPOUNDS, PHARMACEUTICAL COMPOSITION THAT CONTAINS THE COMPOUND AND THE PROCESS OF SUPPLYING THE COMPOUND
DE69729183T2 (en) DIHYDROBENZOFURANES AND RELATED COMPOUNDS USEFUL AS AN ANTI-FLAMMING AGENT
ID24333A (en) PROCESS FOR PROTECTION OF SOMEONE TO THE CONTAMINATION OF THE AS A RESULT OF TRANSDERMAL ORAL USE SYSTEMS WHICH DOESN'T TRUE
ATE272648T1 (en) GLYCOCONJUGATES OF 20(S)-CAMPTOTHECINE
HUP0202729A2 (en) Compositions for parenteral use of estramustine phosphate and amino acids
DE59811656D1 (en) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
ES2170377T3 (en) COMPOSITION CONTAINING QUITOSANA.
HUT75529A (en) Use of dimeticone for treating constipation
ATE220535T1 (en) DENTAL CLEANSER AS GRANULES
AP9600780A0 (en) Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent.